level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 20 /hr
Hire Dr. Divya D.
India
USD 20 /hr

Bioinformatics, data analyst, NGS, R, Scientific writing with 15 years of experience

Profile Summary
Subject Matter Expertise
Services
Writing Non-Medical Regulatory Writing, Technical Writing
Data & AI Statistical Analysis, Data Visualization
Work Experience

Central Drug Research Institute

March 2020 - Present

Education

PhD in bioinformatics

Central Drug Research Institute

May 2004 - May 2010

Certifications
  • Certification details not provided.
Publications
BOOK CHAPTER
Dube, D.(2022). Polo-like kinases: An antimitotic drug target for cancer therapy . Protein Kinase Inhibitors: From Discovery to Therapeutics. p. 457-477.
JOURNAL ARTICLE
Dube D, Tiwari P, Kaur P(2016). The hunt for antimitotic agents: an overview of structure-based design strategies . Expert opinion on drug discovery.
Rani L, Mathur N, Gogia A, Vishnubhatla S, Kumar L, Sharma A, Dube D, Kaur P, Gupta R(2016). Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia . Leukemia & lymphoma.
Rani, L., Mathur, N., Gogia, A., Vishnubhatla, S., Kumar, L., Sharma, A., Dube, D., Kaur, P., Gupta, R.(2016). Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia . Leukemia and Lymphoma. 57. (10). p. 2389-2400.
Dube, D., Tiwari, P., Kaur, P.(2016). The hunt for antimitotic agents: an overview of structure-based design strategies . Expert Opinion on Drug Discovery. 11. (6). p. 579-597.
Dube, D., Sharma, S., Singh, T.P., Kaur, P.(2014). Pharmacophore mapping, in silico screening and molecular docking to identify selective Trypanosoma brucei pteridine reductase inhibitors . Molecular Informatics. 33. (2). p. 124-134.
Sharma, P., Dube, D., Yadav, S.P., Sinha, M., Kaur, P., Sharma, S., Singh, T.P.(2014). Structural and functional studies of mammalian peptidoglycan recognition protein, pgrp-s . Journal of the Indian Institute of Science. 94. (1). p. 109-117.
Nahar, R., Dube, D., Parakh, R., Deb, R., Saxena, R., Singh, T.P., Verma, I.C.(2013). Implication of novel CYP2C9*57 (p.Asn204His) variant in coumarin hypersensitivity . Thrombosis Research. 131. (6). p. 535-539.
Sharma, P., Yamini, S., Dube, D., Singh, A., Mal, G., Pandey, N., Sinha, M., Singh, A.K., Dey, S., Kaur, P., et al.(2013). Structural basis of the binding of fatty acids to peptidoglycan recognition protein, PGRP-S through second binding site . Archives of Biochemistry and Biophysics. 529. (1). p. 1-10.
Sharma, P., Dube, D., Sinha, M., Dey, S., Kaur, P., Sharma, S., Singh, T.P.(2012). Structural basis of heparin binding to camel peptidoglycan recognition protein-S . International Journal of Biochemistry and Molecular Biology. 3. (1). p. 86-94.
Sharma, P., Yamini, S., Dube, D., Singh, A., Sinha, M., Dey, S., Mitra, D.K., Kaur, P., Sharma, S., Singh, T.P.(2012). Structural studies on molecular interactions between camel peptidoglycan recognition protein, CPGRP-S, and peptidoglycan moieties N-acetylglucosamine and N-acetylmuramic acid . Journal of Biological Chemistry. 287. (26). p. 22153-22164.
Kukshal, V., Mishra, M., Ajay, A., Khanam, T., Sharma, R., Dube, D., Chopra, D., Tripathi, R.P., Ramachandran, R.(2012). Synthesis and bioevaluation of aryl hydroxamates distinguishing between NAD <sup>+</sup> and ATP-dependent DNA ligases . MedChemComm. 3. (4). p. 453-461.
Dube, D., Periwal, V., Kumar, M., Sharma, S., Singh, T.P., Kaur, P.(2012). 3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitors . Journal of Molecular Modeling. 18. (5). p. 1701-1711.
Dube D, Periwal V, Kumar M, Sharma S, Singh TP, Kaur P(2011). 3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitors . Journal of molecular modeling.
Paliwal P, Tandon R, Dube D, Kaur P, Sharma A(2011). Familial segregation of a VSX1 mutation adds a new dimension to its role in the causation of keratoconus . Molecular vision.
Paliwal, P., Tandon, R., Dube, D., Kaur, P., Sharma, A.(2011). Familial segregation of a VSX1 mutation adds a new dimension to its role in the causation of keratoconus . Molecular Vision. 17. p. 481-485.
Sharma, P., Dube, D., Sinha, M., Mishra, B., Dey, S., Mal, G., Pathak, K.M.L., Kaur, P., Sharma, S., Singh, T.P.(2011). Multiligand specificity of pathogen-associated molecular pattern-binding site in peptidoglycan recognition protein . Journal of Biological Chemistry. 286. (36). p. 31723-31730.
Sharma, P., Dube, D., Singh, A., Mishra, B., Singh, N., Sinha, M., Dey, S., Kaur, P., Mitra, D.K., Sharma, S., et al.(2011). Structural basis of recognition of pathogen-associated molecular patterns and inhibition of proinflammatory cytokines by camel peptidoglycan recognition protein . Journal of Biological Chemistry. 286. (18). p. 16208-16217.
Tripathi, R.P., Pandey, J., Kukshal, V., Ajay, A., Mishra, M., Dube, D., Chopra, D., Dwivedi, R., Chaturvedi, V., Ramachandran, R.(2011). Synthesis, in silico screening and bioevaluation of dispiro-cycloalkanones as antitubercular and mycobacterial NAD<sup>+</sup>-dependent DNA ligase inhibitors . MedChemComm. 2. (5). p. 378-384.
Paliwal P, Sharma A, Tandon R, Sharma N, Titiyal JS, Sen S, Kaur P, Dube D, Vajpayee RB(2010). TGFBI mutation screening and genotype-phenotype correlation in north Indian patients with corneal dystrophies . Molecular vision.
Paliwal P, Gupta J, Tandon R, Sharma N, Titiyal JS, Kashyap S, Sen S, Kaur P, Dube D, Sharma A, et al.(2010). Identification and characterization of a novel TACSTD2 mutation in gelatinous drop-like corneal dystrophy . Molecular vision.
Kumar, S., Singh, N., Sinha, M., Dube, D., Singh, S.B., Bhushan, A., Kaur, P., Srinivasan, A., Sharma, S., Singh, T.P.(2010). Crystal structure determination and inhibition studies of a novel xylanase and α-amylase inhibitor protein (XAIP) from Scadoxus multiflorus . FEBS Journal. 277. (13). p. 2868-2882.
Kumar, S., Singh, N., Mishra, B., Dube, D., Sinha, M., Singh, S.B., Dey, S., Kaur, P., Sharma, S., Singh, T.P.(2010). Modulation of inhibitory activity of xylanase - α-amylase inhibitor protein (XAIP): Binding studies and crystal structure determination of XAIP- II from Scadoxus multiflorus at 1.2 Å resolution . BMC Structural Biology. 10.
Paliwal, P., Sharma, A., Tandon, R., Sharma, N., Titiyal, J.S., Sen, S., Kaur, P., Dube, D., Vajpayee, R.B.(2010). TGFBI mutation screening and genotype-phenotype correlation in north Indian patients with corneal dystrophies . Molecular Vision. 16. p. 1429-1438.
Paliwal, P., Gupta, J., Tandon, R., Sharma, N., Titiyal, J.S., Kashyap, S., Sen, S., Kaur, P., Dube, D., Sharma, A., et al.(2010). Identification and characterization of a novel TACSTD2 mutation in gelatinous drop-like corneal dystrophy . Molecular Vision. 16. p. 729-739.
Misra, G., Aggarwal, A., Dube, D., Zaman, M.S., Singh, Y., Ramachandran, R.(2009). Crystal structure of the Bacillus anthracis nucleoside diphosphate kinase and its characterization reveals an enzyme adapted to perform under stress conditions . Proteins: Structure, Function and Bioinformatics. 76. (2). p. 496-506.
Pandey, J., Sharma, A., Tiwari, V.K., Dube, D., Ramachandran, R., Chaturvedi, V., Sinha, S.K., Mishra, N.N., Shukla, P.K., Tripathi, R.P.(2009). Solution-phase synthesis of a library of carbapeptide analogues based on glycosylamino acid scaffolds and their in silico screening and antimicrobial evaluation . Journal of Combinatorial Chemistry. 11. (3). p. 422-427.
Dwivedi, N., Dube, D., Pandey, J., Singh, B., Kukshal, V., Ramachandran, R., Tripathi, R.P.(2008). NAD<sup>+</sup>-dependent DNA ligase: A novel target waiting for the right inhibitor . Medicinal Research Reviews. 28. (4). p. 545-568.
Srivastava, S.K., Dube, D., Kukshal, V., Jha, A.K., Hajela, K., Ramachandran, R.(2007). NAD<sup>+</sup>-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: Novel structure-function relationship and identification of a specific inhibitor . Proteins: Structure, Function and Genetics. 69. (1). p. 97-111.
Srivastava SK, Dube D, Tewari N, Dwivedi N, Tripathi RP, Ramachandran R(2005). Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I . Nucleic acids research.
Srivastava, S.K., Dube, D., Tewari, N., Dwivedi, N., Tripathi, R.P., Ramachandran, R.(2005). Mycobacterium tuberculosis NAD<sup>+</sup>-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I . Nucleic Acids Research. 33. (22). p. 7090-7101.
CONFERENCE PAPER
Dube, D., Kukshal, V., Srivastava, S.K., Tripathi, R.P., Ramachandran, R.(2008). NAD<sup>+</sup>-dependent DNA ligase (Rv3014c) from M. tuberculosis: Strategies for inhibitor design . Medicinal Chemistry Research. 17. (2-7). p. 189-198.
Dube, D., Srivastava, S.K., Kukshal, V., Tripathi, R.P., Ramachandran, R.(2006). Novel specific inhibitors of NAD<sup>+</sup>-dependent DNA ligase (RV3014C) from M. tuberculosis identified from virtual screening . Medicinal Chemistry Research. 15. (1-6). p. 93-94.